Vascular AGE-ing by methylglyoxal: the past, the present and the future
Open Access
- 12 May 2015
- journal article
- editorial
- Published by Springer Nature in Diabetologia
- Vol. 58 (8) , 1715-1719
Abstract
Over the years, new research has elucidated the importance of the very fast formation of AGEs by the highly reactive methylglyoxal (MGO). It has become clear that MGO triggers maladaptive responses in vascular tissue. To counteract the deleterious effects of MGO, organisms have an enzymatic glyoxalase defence system in which MGO is converted to d-lactate, with glyoxalase 1 (GLO1) as the key enzyme in this system. Significant progress has been made towards the understanding of the MGO–GLO1 pathway in the pathogenesis of vascular disease in diabetes. This commentary highlights some lines of current research and future perspectives. The work conducted so far is only the starting point—in the coming 50 years, the MGO–GLO1 pathway will be the subject of intensified research, with special focus on pathophysiological pathways, the use of this system for early screening and risk prediction, and the development of intervention strategies for preventing vascular complications in people with and without diabetes. This is one of a series of commentaries under the banner ‘50 years forward’, giving personal opinions on future perspectives in diabetes, to celebrate the 50th anniversary of Diabetologia (1965–2015).Keywords
This publication has 15 references indexed in Scilit:
- Measurement of methylglyoxal by stable isotopic dilution analysis LC-MS/MS with corroborative prediction in physiological samplesNature Protocols, 2014
- Integrative Genomics Reveals Novel Molecular Pathways and Gene Networks for Coronary Artery DiseasePLOS Genetics, 2014
- The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEsBiochemistry, 2014
- Dicarbonyl proteome and genome damage in metabolic and vascular diseaseBiochemical Society Transactions, 2014
- Global estimates of diabetes prevalence for 2013 and projections for 2035Diabetes Research and Clinical Practice, 2014
- Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotypeEuropean Heart Journal, 2013
- Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathyNature Medicine, 2012
- Transcriptional control of glyoxalase 1 by Nrf2 provides a stress-responsive defence against dicarbonyl glycationBiochemical Journal, 2012
- Postprandial Blood Glucose Predicts Cardiovascular Events and All-Cause Mortality in Type 2 Diabetes in a 14-Year Follow-UpDiabetes Care, 2011
- Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemiaJournal of Experimental Medicine, 2008